Netherlands Society of Gene and Cell Therapy

Binnen de afdeling Gentechnologie en Biologische Veiligheid (RIVM) zijn ze op zoek naar een ervaren viroloog om het team te komen versterken. Meer informatie over deze vacature is hier te vinden. Sluitingsdatum is 17 september 2021.

News

Postdoc vacature bij het RIVM

Intellia and Regeneron Announce Landmark Clinical Data Showing Deep Reduction in Disease-Causing Protein After Single Infusion of NTLA-2001, an Investigational CRISPR Therapy for Transthyretin (ATTR) Amyloidosis

Biogen Announces Topline Results From Phase 2/3 Gene Therapy Study for XLRP

Sarepta Therapeutics Reports Positive Clinical Results from Phase 2 MOMENTUM Study of SRP-5051 in Patients with Duchenne Muscular Dystrophy Amenable to Skipping Exon 51

Adverum Biotechnologies announced a Suspected Unexpected Serious Adverse Reaction (SUSAR) of hypotony (clinically-relevant decrease in ocular pressure) in its INFINITY clinical trial evaluating ADVM-022 gene therapy for the treatment of diabetic macular edema